GlassScriptPhysician profile
Kevin M Charron
NPI 1699898437
$33,008.12
in general payments reported to CMS, 2019-2025
26 companies · $1,021 in 2025
The $1,021 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $8,267 · 2021: $101 · 2022: $6,392 · 2023: $54.32 · 2024: $215 · 2025: $1,021.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $774 · Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $773.87 |
| Food and Beverage | $516.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $29,302.96 | 2019-2025 | |
| United Orthopedics LLC | $2,329.98 | 2020-2025 | |
| Horizon Therapeutics Plc | $577.36 | 2019-2022 | |
| Ermi LLC | $92.28 | 2024-2025 | |
| Abbvie INC. | $82.79 | 2024 | |
| Pacira Therapeutics, INC. | $80.74 | 2019-2020 | |
| Depuy Synthes Sales INC. | $57.92 | 2019-2024 | Dynacord |
| Illuminoss Medical, INC. | $54.32 | 2023 | Photodynamic Bone Stabilization Procedure Pack |
| Vertos Medical, INC. | $45.39 | 2019 | |
| Zimmer Biomet Holdings, INC. | $44.94 | 2019 | |
| Ferring Pharmaceuticals INC. | $38.03 | 2019-2021 | |
| Orthogenrx INC. | $34.85 | 2019-2021 | |
| Davol INC. | $30.18 | 2025 | |
| Smith+Nephew, INC. | $29.59 | 2025 | Allevyn Life L 15.4x15.4 Ctn10 |
| Zyla Life Sciences, INC. | $28.07 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $24.50 | 2024 | Xiaflex |
| Bioventus LLC | $20.85 | 2025 | Durolane |
| Endo Pharmaceuticals INC. | $19.70 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.01 | 2020 | |
| Orthofix Medical, INC. | $17.78 | 2019-2025 | Physio-Stim |
| Heron Therapeutics, INC. | $15.07 | 2024 | Zynrelef |
| Integra Lifesciences Corporation | $14.06 | 2019 | |
| Vericel Corporation | $13.47 | 2024 | Maci |
| Heraeus Medical, LLC. | $12.70 | 2019 | |
| Polarityte, INC. | $11.42 | 2019 | |
| Kerecis Limited | $11.16 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Charron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.